Navigation Links
Cell Therapeutics Reports Second Quarter 2013 Financial Results
Date:7/31/2013

lifesciences.com">lvilla@cti-lifesciences.com
CTI_EUInvestors@CTI-Lifesciences.com

 

 Cell Therapeutics, Inc.Condensed Consolidated Statements of Operations(In thousands, except for per share amounts)(unaudited)Three Months EndedSix Months EndedJune 30,June 30,2013201220132012Revenues:Product sales, net$
306$
-$
,432$
-Total revenues306-1,432-Operating costs and expenses:Cost of product sold36-91-Research and development8,0208,95916,37517,129Selling, general and administrative10,10211,33321,24521,261Acquired in-process research and development-29,108-29,108Total operating costs and expenses18,15849,40037,71167,498Loss from operations(17,852)(49,400)(36,279)(67,498)Other income (expense):Investment and other income (expense), net107(99)(260)91Interest expense(316)(3)(364)(8)Amortization of debt discount and issuance costs(164)-(187)-Foreign exchange gain (loss)5(696)(746)(312)Net loss before noncontrolling interest(18,220)(50,198)(37,836)(67,727)Noncontrolling interest20960441143Net loss attributable to CTI(18,011)(50,138)(37,395)(67,584)Deemed dividends on preferred stock-(8,458)-(8,458)Net loss attributable to CTI common shareholders$ (18,011)$ (58,596)$ (37,395)$ (76,042)Basic and diluted net loss per common share $
(0.17)
$
(1.38)
$
(0.35)
$
(1.83)
Shares used in calculation of basic and dilutednet loss per common share107,72742,532107,21541,662Balance Sheet Data (unaudited):(amounts in thousands)June 30,December 31,20132012Cash and cash equivalents $  28,568$  50,436Working capital13,03337,644T
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has been ... business is showing its latest designs of wedding dresses and ... the company’s CEO, all the fresh new products are designed ... up to 80% off. All the clothes from LunaDress follow ...
(Date:1/22/2015)... is a seasoned and trusted leader who consistently delivers trendy ... have it lead the wedding dress industry into the future. ... for the global market. , “The CEO of VogueQueen is ... on continuing the goal of operational excellence and giving back ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... treatments to prevent lower limb amputations in diabetes - which ... Diabetes UK). , The research from the University of Bristol ... funded by the British Heart Foundation (BHF) and the European ... have serious complications like gangrene and skin ulcers due to ...
... the list; over 2,500 neighborhoods ranked, SEATTLE, ... company,that operates walkability site http://www.walkscore.com, today ... Most Walkable,Neighborhoods. With gas topping $4 per gallon, ... The new list is the first objective,national ranking ...
... held medical device manufacturer focusing on minimally invasive ... that the company has closed a Series C ... capital firms active in medical technology. The lead ... Partners and were joined in the round by ...
... Action applauds the,Senate for overwhelming, bipartisan passage ... Tuberculosis, and Malaria Reauthorization Act,(S 2731), which ... Relief,(PEPFAR). The organization particularly commends the lifting ... immigration to the U.S. by HIV,positive non-citizens. ...
... 16 While Lorillard Tobacco,Company (a wholly-owned subsidiary of ... the opportunity to fully review the latest report from ... that the report reaffirms,its view with respect to the ... including that:, -- "The available [scientific] evidence remains ...
... The following is a,statement by Tom Epstein, Vice President, ... the Los Angeles City Attorney is totally without,merit., ... by two,state agencies that have aggressively defended the interests ... seized on a hot topic in an,attempt to advance ...
Cached Medicine News:Health News:Insight into mechanisms of diabetes-induced microvascular disease reveals new therapies 2Health News:Walk Score Unveils America's Most Walkable Neighborhoods 2Health News:Vertos Medical Inc. Completes Series C Financing 2Health News:Vertos Medical Inc. Completes Series C Financing 3Health News:Vertos Medical Inc. Completes Series C Financing 4Health News:Lorillard Tobacco Company Comments on Harvard School of Public Health Report 2Health News:Lorillard Tobacco Company Comments on Harvard School of Public Health Report 3Health News:Statement Regarding Los Angeles City Attorney Enforcement Action 2
... Model 6495 Bipolar Coaxial Temporary Pacing Lead ... bipolar technology based on the sensing and ... Unipolar Temporary Pacing Lead., ,The Streamline Temporary ... temporary sensing and pacing during and after ...
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... to provide consistent temporary sensing and pacing ...
... device was designed specifically to obviate the ... The eNcloseII device can provide the surgeon ... better hemodynamics as compared to partial occlusion ... suggested that complete or partial clamping of ...
... Carpentier-Edwards Classic annuloplasty rings have ... choice for more than 30 ... restore the anatomical size and ... to help prevent recurrent dilatation. ...
Medicine Products: